Dr. Morice’s contributions to the PCR mission are to be recognized in the EuroPCR 2021 course
Taking place online from May 18-20, 2021, EuroPCR is an opportunity for the interventional cardiovascular community to come together and benefit from interactive peer-to-peer training. At this year’s web-based event, Dr. Marie-Claude Morice received the Andreas Grüntzig Ethica Award for her contribution to education, training and clinical research in interventional cardiology.
The Andreas Grüntzig Ethica Award is presented each year to an outstanding colleague who has contributed to the PCR mission in an extraordinary way: It serves the needs of every individual patient by helping the cardiovascular community to exchange knowledge, experience and practice. Dr. As a practitioner, researcher and mentor, Morice is a perfect example of what PCR stands for and a well-deserved recipient of this year’s award. The ceremony will take place on Thursday, May 20th at 11:45 am Paris time on the main arena canal.
A practitioner and clinical scientist
Dr. Marie-Claude Morice was selected as the recipient of this year’s award for her work as a leading researcher and practitioner in interventional cardiology with an impressive career spanning over four decades. This award recognizes four visionary contributions of Marie-Claude Morice’s research into the practice of interventional cardiology, which have had an enormous impact on the well-being of patients:
- Pioneered the use of the antiplatelet drug clopidogrel to prevent acute and chronic thrombosis after percutaneous coronary intervention (PCI) with or without the use of a stent to replace several ineffective anticoagulants.
- Contributing to the validation and adoption of active drug-eluting stents in daily practice as the main researcher in many studies including the very first study – the RAVEL study.
- Expansion of the PCI indications to include multiple vessel coronary artery disease, and particularly left major coronary artery disease, which was previously mistakenly viewed as a subset of “no-touch” lesions for interventionists.
- Identify an “orphaned” group of patients at high risk of bleeding (HBR) and establish the limits of targeted antiplatelet therapy through specific studies to reduce bleeding without increasing ischemic risk.
Contribution to the learning continuum
Dr. Marie-Claude Morice has shown great commitment to education and training, with a particular focus on young professionals. As part of her determination to help others learn and practice, she was involved in creating the PCR clinical research program, which is open to everyone involved in the clinical research process. She is the woman behind the creation of the PCR Tokyo Valves Course and the dedicated dedication and leadership of Dr. Saito-san and Dr. Kentaro Hayashida, one of her students. Through these initiatives, Marie-Claude has embraced PCR’s mission and shared her knowledge, experience and practice in cardiovascular interventional medicine to help younger generations of practitioners get one foot on the ladder. Her commitment has been invaluable to many of her young colleagues, including Davide Capodanno, Christopher Cook, Dejan Milasinovich, and Kentaro Hayashida through PCR Clinical Research and PCR Tokyo Valves.
An advocate for gender equality
Dr. Morice was and is a major player in the fight for gender equality. Their struggle has targeted society at large and, of course, the world of interventional cardiology, with a particular focus on patients. In particular, she has carried out research examining the effects of gender on access to care and the different outcomes of therapies. Firmly believing that women have a place in medicine, she is a co-founder of Women as One, an initiative that nurtures talent in medicine and cardiology by providing women doctors with unique career opportunities.
NOTES TO THE EDITORS
Dates to remember
- EuroPCR course – 18.-20. May 2021 – Livestream program
- Andreas Grüntzig Ethica Award – May 20, 2021, 11.45 a.m. Paris time – main channel of the arena
About EuroPCR 2021
The world’s leading course in interventional cardiovascular medicine and the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) will take place online from May 18-20, 2021. This virtual course will bring the interventional cardiovascular community together to share knowledge, skills and experience to better care for patients around the world. This year new interactive learning methods will be offered.
The detailed interactive program can be found here.
PCR’s mission is to meet the needs of every individual patient by helping the cardiovascular community share knowledge, experience and practice. PCR offers a wide range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include key annual courses around the world, e-learning with high-profile PCR webinars, courses specific to heart valve disease, tailored PCR seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.
Gateways to all PCR activities can be found at http: // www.
For more information, please contact Célia Vila: [email protected]